Exact Mass: 572.3097504

Exact Mass Matches: 572.3097504

Found 75 metabolites which its exact mass value is equals to given mass value 572.3097504, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Bioadykinin Fragment 1-5

2-({2-[({1-[1-(2-amino-5-carbamimidamidopentanoyl)pyrrolidine-2-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-1-hydroxyethylidene}amino)-3-phenylpropanoate

C27H40N8O6 (572.3070660000001)


   
   
   
   
   
   
   

12(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside J

12(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside J

C29H48O11 (572.3196458)


   
   
   
   
   
   

13(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside I

13(R)-(6-O-acetyl-3-O-malonyl-beta-D-glucopyranosyloxy)octadecanoic acid 1,2-cyclic ester|gallicaside I

C29H48O11 (572.3196458)


   
   
   

1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone

NCGC00180261-02!1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone

C25H44N6O9 (572.3169614)


   

1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based: Match]

NCGC00180261-02!1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based: Match]

C25H44N6O9 (572.3169614)


   

1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based on: CCMSLIB00000845569]

NCGC00180261-02!1,11,21-trihydroxy-1,6,11,16,21,26-hexazacyclohentriacontane-2,5,12,15,22,25-hexone [IIN-based on: CCMSLIB00000845569]

C25H44N6O9 (572.3169614)


   

Phe Phe Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C33H40N4O5 (572.299855)


   

Phe Phe Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C33H40N4O5 (572.299855)


   

Phe Phe Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C33H40N4O5 (572.299855)


   

Phe Phe Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C33H40N4O5 (572.299855)


   

Phe Ile Phe Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C33H40N4O5 (572.299855)


   

Phe Leu Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C33H40N4O5 (572.299855)


   

Ile Phe Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C33H40N4O5 (572.299855)


   

Leu Phe Phe Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C33H40N4O5 (572.299855)


   

Asn Gln Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C21H40N12O7 (572.314277)


   

Asn Arg Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C21H40N12O7 (572.314277)


   

Asn Arg Arg Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C21H40N12O7 (572.314277)


   

Gln Asn Arg Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanoic acid

C21H40N12O7 (572.314277)


   

Gln Arg Asn Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid

C21H40N12O7 (572.314277)


   

Gln Arg Arg Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid

C21H40N12O7 (572.314277)


   

Arg Asn Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C21H40N12O7 (572.314277)


   

Arg Asn Arg Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C21H40N12O7 (572.314277)


   

Arg Gln Asn Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid

C21H40N12O7 (572.314277)


   

Arg Gln Arg Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid

C21H40N12O7 (572.314277)


   

Arg Arg Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C21H40N12O7 (572.314277)


   

Arg Arg Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C21H40N12O7 (572.314277)


   
   

Arg-Asn-Gln-Arg

Arg-Asn-Gln-Arg

C21H40N12O7 (572.314277)


A tetrapeptide composed of L-arginine, L-asparagine, L-glutamine, and L-arginine joined in sequence by peptide linkages.

   
   
   
   
   
   
   
   
   
   
   
   
   
   

Bradykinin (1-5)

Bradykinin (1-5)

C27H40N8O6 (572.3070660000001)


Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE). Bradykinin (1-5) is a major stable metabolite of Bradykinin, formed by the proteolytic action of angiotensin-converting enzyme (ACE).

   

LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)

LSKL, Inhibitor of Thrombospondin (TSP-1) (TFA)

C23H43F3N6O7 (572.3145164)


LSKL, Inhibitor of Thrombospondin (TSP-1) TFA is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) TFA suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) TFA can readily crosse the blood-brain barrier[1][2].

   

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

SLLK, Control Peptide for TSP1 Inhibitor(TFA)

C23H43F3N6O7 (572.3145164)


SLLK, Control Peptide for TSP1 Inhibitor (TFA) is a control peptide for LSKL, which is a Thrombospondin (TSP-1) inhibitor.

   

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,28e,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,28e,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

C37H40N4O2 (572.31511)


   

3-{[(2r,3r,4s,4ar,18r,19ar)-2-[(acetyloxy)methyl]-3-hydroxy-6-oxo-18-pentyl-hexadecahydro-2h-pyrano[2,3-b]1,4-dioxacycloheptadecan-4-yl]oxy}-3-oxopropanoic acid

3-{[(2r,3r,4s,4ar,18r,19ar)-2-[(acetyloxy)methyl]-3-hydroxy-6-oxo-18-pentyl-hexadecahydro-2h-pyrano[2,3-b]1,4-dioxacycloheptadecan-4-yl]oxy}-3-oxopropanoic acid

C29H48O11 (572.3196458)


   

(2s,3s,4r,5r,6r)-3,5-dihydroxy-2-methyl-6-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-4-yl acetate

(2s,3s,4r,5r,6r)-3,5-dihydroxy-2-methyl-6-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-4-yl acetate

C29H48O11 (572.3196458)


   

3-({2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl}oxy)-3-oxopropanoic acid

3-({2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl}oxy)-3-oxopropanoic acid

C29H48O11 (572.3196458)


   

(1r,3s,5s,6r)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (1s,3r,5r,6s)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2z)-2-methylbut-2-enedioate

(1r,3s,5s,6r)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (1s,3r,5r,6s)-8-methyl-6-[(3-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-3-yl (2z)-2-methylbut-2-enedioate

C31H44N2O8 (572.3097504)


   

3,5-dihydroxy-2-methyl-6-({3,4,5-trihydroxy-6-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-2-yl}methoxy)oxan-4-yl acetate

3,5-dihydroxy-2-methyl-6-({3,4,5-trihydroxy-6-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-2-yl}methoxy)oxan-4-yl acetate

C29H48O11 (572.3196458)


   

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

[(1r,9r,10s,11r,13s,17r,25r,26s,27r,33s,36s,38z,39s)-38-ethylidene-35-oxa-8,14,24,30-tetraazadodecacyclo[25.5.2.2¹¹,¹⁴.1¹,⁸.1⁹,²⁵.1¹⁰,¹⁷.0²,⁷.0¹³,¹⁷.0¹⁸,²³.0³⁰,³³.0²⁴,³⁶.0²⁶,³⁹]nonatriaconta-2,4,6,18,20,22-hexaen-28-ylidene]methanol

C37H40N4O2 (572.31511)


   

bis[(1r,3r,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl] (2e)-2-methylbut-2-enedioate

bis[(1r,3r,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl] (2e)-2-methylbut-2-enedioate

C31H44N2O8 (572.3097504)


   

3-({2-[(acetyloxy)methyl]-3-hydroxy-6-oxo-18-pentyl-hexadecahydro-2h-pyrano[2,3-b]1,4-dioxacycloheptadecan-4-yl}oxy)-3-oxopropanoic acid

3-({2-[(acetyloxy)methyl]-3-hydroxy-6-oxo-18-pentyl-hexadecahydro-2h-pyrano[2,3-b]1,4-dioxacycloheptadecan-4-yl}oxy)-3-oxopropanoic acid

C29H48O11 (572.3196458)


   

{11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-aminobenzoate

{11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl}methyl 2-aminobenzoate

C31H44N2O8 (572.3097504)


   

1,5,11,15,21,25-hexahydroxy-1,6,11,16,21,26-hexaazacyclohentriaconta-5,15,25-triene-2,12,22-trione

1,5,11,15,21,25-hexahydroxy-1,6,11,16,21,26-hexaazacyclohentriaconta-5,15,25-triene-2,12,22-trione

C25H44N6O9 (572.3169614)


   

(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-3-yl acetate

(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-3-yl acetate

C29H48O11 (572.3196458)


   

(1s,3r,5r,6s)-8-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (1r,3s,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate

(1s,3r,5r,6s)-8-methyl-3-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (1r,3s,5s,6r)-8-methyl-6-{[(2z)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-2-methylbut-2-enedioate

C31H44N2O8 (572.3097504)


   

3-{[(2r,3r,4s,4ar,17r,18ar)-2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl]oxy}-3-oxopropanoic acid

3-{[(2r,3r,4s,4ar,17r,18ar)-2-[(acetyloxy)methyl]-17-hexyl-3-hydroxy-6-oxo-hexadecahydropyrano[2,3-b]1,4-dioxacyclohexadecan-4-yl]oxy}-3-oxopropanoic acid

C29H48O11 (572.3196458)


   

(11e,13e)-16-ethyl-4,6,7-trihydroxy-15-{[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxy]methyl}-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

(11e,13e)-16-ethyl-4,6,7-trihydroxy-15-{[(5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl)oxy]methyl}-5,9,13-trimethyl-1-oxacyclohexadeca-11,13-diene-2,10-dione

C29H48O11 (572.3196458)


   

[(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

[(1s,2r,3r,4s,5s,6s,8r,9s,10s,13s,16r,17r,18s)-11-ethyl-4,8,9-trihydroxy-6,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-13-yl]methyl 2-aminobenzoate

C31H44N2O8 (572.3097504)


   

(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-3-yl acetate

(2r,3r,4r,5r,6s)-4,5-dihydroxy-6-methyl-2-{[(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-2-yl]methoxy}oxan-3-yl acetate

C29H48O11 (572.3196458)


   

4,5-dihydroxy-6-methyl-2-({3,4,5-trihydroxy-6-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-2-yl}methoxy)oxan-3-yl acetate

4,5-dihydroxy-6-methyl-2-({3,4,5-trihydroxy-6-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-2-yl}methoxy)oxan-3-yl acetate

C29H48O11 (572.3196458)